Unlock instant, AI-driven research and patent intelligence for your innovation.

Cross-linked pyrrolobenzodiazepine*dimer (PBD) derivative and its conjugates

A technology of benzodiazepine dimer and bipyrrole, which is applied in the field of novel cross-linkable cytotoxic agents and can solve problems such as patient death

Inactive Publication Date: 2021-01-26
HANGZHOU DAC BIOTECH
View PDF33 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unfortunately, the drug Vadastuximab talirine (a CD33 antibody-PBD conjugate linked with a conditionally restricted stable linker) (Stein, E.M. et al., Blood, 2018, 131, 387-96), which has the fastest clinical progress, is due to liver Setback due to toxicity, which resulted in the death of four patients in early trials (www.xconomy.com / seattle / 2017 / 06 / 19)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cross-linked pyrrolobenzodiazepine*dimer (PBD) derivative and its conjugates
  • Cross-linked pyrrolobenzodiazepine*dimer (PBD) derivative and its conjugates
  • Cross-linked pyrrolobenzodiazepine*dimer (PBD) derivative and its conjugates

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0399] Embodiment 1.1, the synthesis of 2-bis(2-(tert-butoxy)-2-oxyethyl)hydrazine-1,2-dicarboxylic acid di-tert-butyl ester

[0400]

[0401] To a solution of di-tert-butyl di-tert-butylhydrazine-1,2-dicarboxylate (8.01 g, 34.4 mmol) in DMF (150 mL) was added NaH (60%, 2.76 g, 68.8 mmol). After stirring at room temperature for 30 minutes, tert-butyl 2-bromoacetate (14.01 g, 72.1 mmol) was added. The mixture was stirred overnight, quenched by the addition of methanol (3 mL), concentrated, diluted with ethyl acetate (100 mL) and water (100 mL), separated, and the aqueous layer was extracted with ethyl acetate (2 x 50 mL). The combined organic layers were washed with MgSO 4 dried, filtered, concentrated, and passed through SiO 2 Purification by column chromatography (ethyl acetate / hexane 1:5 to 1:3) afforded the title compound (12.98 g, 82% yield) as a colorless oil. MS ESI m / z C 22 h 41 N 2 o 8 [M+H] + : The calculated value is 461.28, and the measured value is 461.4...

Embodiment 2

[0402] Example 2. Synthesis of 2,2'-(hydrazino-1,2-diyl)diacetic acid.

[0403]

[0404] 1, 4 - Add HCL (12M, 10mL) to dioxane (40mL). The mixture was stirred for 30 minutes, diluted with dioxane (20mL) and toluene (40mL), concentrated and mixed with dioxane (20mL) and toluene (40mL) Evaporation to dryness gave the crude product which was used in the next step without further purification (2.15 g, 103% yield, 93% purity). MS ESI m / z C 4 h 9 N 2 o 4 [M+H] + : The calculated value is 149.05, and the measured value is 149.40.

Embodiment 3

[0405] Example 3. 2,2'-(1,2-bis((benzyloxy)carbonyl)hydrazine-1,2-diyl)synthesis of diacetic acid

[0406]

[0407] To 2,2'-(hydrazine-1,2-diyl)diacetic acid (1.10 g, 7.43 mmol) in THF (200 mL) and NaH 2 PO 4 (0.1 M, 250 mL, pH 8.0) was added benzyl phosgene (5.01 g, 29.47 mmol) in 4 portions over two hours. The mixture was stirred for another 6 h, concentrated and purified on a silica gel column with 1% formic acid in H 2 O / CH 3 CN (1:9) eluted to give the title compound (2.26 g, 73% yield, 95% purity). MS ESI m / z C 20 h 21 N 2 o 8 [M+H] + : The calculated value is 417.12, and the measured value is 417.40.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a novel cross-linked cytotoxic agents, pyrrolobenzo-diazepine dimer (PBD) derivatives, and their conjugates to a cell-binding molecule, a method for preparation of theconjugates and the therapeutic use of the conjugates.

Description

[0001] field of invention [0002] The present application relates to novel cross-linkable cytotoxic agents, pyrrolobenzodiazepines Dimer (PBD) derivatives, and their conjugates with cell-binding molecules, processes for the preparation of the conjugates, and therapeutic uses of the conjugates. [0003] Background of the invention [0004] Antibody-drug conjugates (ADCs) have broad prospects as anticancer drugs. At present, four ADC drugs have been approved by the FDA, and more than 100 ADC drugs using several different classes of cytotoxic agents have been approved for clinical research. Such as mytansine (Zhao, Robert Y. et al., J. Med. Chem., 2011, 54, 3606; Widdison, W. et al., J. Med. Chem., 2006, 49, 4392-4408); Auristatin (autistatin) and its parent compound dolastatin (dolastatin) (Doronina, S.O. et al., Nat.Biotechnol., 2003, 21(7), 778-784; Maderna, A., J.Med.Chem., 2014, 57(24), 10527–10543); calicheamycin (Ricart, A.D. Clin. Cancer Res., 2011, 17, 6417-6427; Rica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D487/04A61K31/5517A61P35/00
CPCA61P35/00C07D487/22A61K47/6855A61K47/6889A61K47/68035A61P37/00A61P31/00A61K47/545A61K47/55A61K31/5517A61K45/06C07D519/00
Inventor R·Y·赵杨庆良赵林尧黄圆圆叶杭波盖顺郭辉辉贾军祥白露周晓迈郭芝香李雯君叶智鸧杨焱磊其他发明人请求不公开姓名
Owner HANGZHOU DAC BIOTECH